摘要
目的研究分析45例上消化道出血患者应用消化内镜治疗后的止血效果、安全性、可行性,为临床治疗上消化道出血患者提供相应的参考依据。方法 2017年8月至2018年8月,本院共收治上消化道出血患者90例,应用随机抽样法将90例患者分为内镜组与常规组。内镜组患者应用消化内镜治疗,常规组患者应用常规药物治疗,对比两组上消化道出血患者的止血时间、住院时间、治疗费用、临床疗效、并发症发生率、再出血率。结果两组上消化道出血患者实施治疗后,内镜组患者的止血时间、住院时间、并发症发生率、再出血率均少于常规组,差异显著具有统计学意义(P <0.05);内镜组患者的临床疗效与治疗费用均高于常规组,差异显著具有统计学意义(P <0.05)。结论消化内镜治疗上消化道出血具有显著优势,安全性高,疗效确切,更值得在临床推广。
Objective To analyze the hemostatic effect,safety and feasibility of 45 patients with upper gastrointestinal hemorrhage after digestive endoscopic treatment,and to provide a reference for clinical treatment of patients with upper gastrointestinal bleeding.Methods From August 2017 to August 2018,90 patients with upper gastrointestinal hemorrhage were treated in our hospital.90 patients were divided into endoscopy group and routine group by random sampling method.Endoscopic group was treated with digestive endoscopy.The routine group was treated with conventional drug therapy,and the hemostasis time,hospitalization time,treatment cost,clinical effi cacy,complication rate,and rebleeding rate of the patients with upper gastrointestinal hemorrhage were compared.Results After treatment in patients with upper gastrointestinal hemorrhage,the time of hemostasis,hospitalization time,complication rate and rebleeding rate were lower in the endoscopy group than in the routine group,and the diff erence was statistically signifi cant(P<0.05).The clinical efficacy and treatment cost of the patients in the endoscopy group were higher than those in the routine group,and the difference was statistically signifi cant(P<0.05).Conclusion Digestive endoscopy has a signifi cant advantage in the treatment of upper gastrointestinal hemorrhage,high safety,exact curative effect,and more worthy of clinical promotion.
作者
赵宏巍
ZHAO Hongwei(Central Hospital of Yingkou Economic and Technological Development Zone,the Sixth People's Hospital of Yingkou,Yingkou 115007,China)
出处
《中国医药指南》
2020年第24期81-82,共2页
Guide of China Medicine
关键词
上消化道出血
消化内镜
常规药物
止血时间
再出血
治疗费用
Upper gastrointestinal bleeding
Digestive endoscopy
Conventional drugs
Hemostasis time
Rebleeding
Treatment costs